Emergent BioSolutions (EBS) Income from Non-Controlling Interests (2011 - 2013)
Emergent BioSolutions (EBS) posted Income from Non-Controlling Interests of -$5000.0 for Q4 2013, up 96.09% on a QoQ basis from -$128000.0 in Q2 2013, and up 99.55% year-over-year from -$2505.7 in Q4 2012.
Powered by 
Analysis
Emergent BioSolutions (EBS) Income from Non-Controlling Interests (2011 - 2013) Analysis & Trends
Emergent BioSolutions has reported Income from Non-Controlling Interests for 3 years, with the latest figure at -$5000.0 in Q4 2013.
- On a quarterly basis, Income from Non-Controlling Interests rose 99.55% year-over-year to -$5000.0 in Q4 2013; TTM through Sep 2014 was -$5000.0, a 99.75% increase from a year earlier, with the FY2018 full-year figure at -$5.8 million, down 45.0% from the prior year.
- Income from Non-Controlling Interests was -$5000.0 for Q4 2013 at Emergent BioSolutions, up from -$128000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was -$5000.0 in Q4 2013, with the low at -$2.1 million in Q2 2012.
- Average Income from Non-Controlling Interests over 3 years is -$1.1 million, with a median of -$1.1 million recorded in 2012.
- The sharpest annual moves came in 2012 and 2013: Income from Non-Controlling Interests decreased 23.65% in 2012, then soared 99.55% in 2013.
- Over 3 years, Income from Non-Controlling Interests stood at -$1.8 million in 2011, then jumped by 37.11% to -$1.1 million in 2012, then jumped by 99.55% to -$5000.0 in 2013.
- The last three Income from Non-Controlling Interests figures came in at -$5000.0 (Q4 2013), -$128000.0 (Q2 2013), and -$743000.0 (Q1 2013), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 10.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | -1.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 39.52 Mn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | - |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | -5,000.00 |
| Jun 30, 2013 | -128,000.00 |
| Mar 31, 2013 | -743,000.00 |
| Dec 31, 2012 | -1.11 Mn |
| Sep 30, 2012 | -997,000.00 |
| Jun 30, 2012 | -2.09 Mn |
| Mar 31, 2012 | -1.19 Mn |
| Dec 31, 2011 | -1.76 Mn |
| Sep 30, 2011 | -1.69 Mn |
| Jun 30, 2011 | -1.69 Mn |
API Access
Emergent BioSolutions Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();